Eve Burstein
Stock Analyst at Bernstein
(2.33)
# 2,536
Out of 4,876 analysts
23
Total ratings
38.46%
Success rate
4.84%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $119.76 | +4.38% | 4 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $169.02 | +18.33% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $98.38 | +47.39% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $357.82 | +0.61% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $54.25 | +65.90% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $51.63 | -32.20% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $413.14 | +50.07% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.29 | +93.80% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $13.71 | +60.53% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $94.74 | +17.16% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $119.76
Upside: +4.38%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $169.02
Upside: +18.33%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $98.38
Upside: +47.39%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $357.82
Upside: +0.61%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $54.25
Upside: +65.90%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $51.63
Upside: -32.20%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $413.14
Upside: +50.07%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.29
Upside: +93.80%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $13.71
Upside: +60.53%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $94.74
Upside: +17.16%